Site Menu
発表論文 2008年
Links
1.Kudoh, T.; Murayama, T.; Hashii, M.; Higashida, H.; Sakurai, T.; Maechling, C.; Spiess, B.; Weber, K.; Guse, A. H.; Potter, B. V. L.; Arisawa, M.; Matsuda, A.; Shuto, S.
Design and synthesis of 4´´, 6´´-unsaturated cyclic ADP-carbocyclic ribose, a Ca2+ mobilizing agent selectively active in T cells.
Tetrahedron, 2008, 64, 9754-9765. DOI: 10.1016/j.tet.2008.07.068
2.Yamaguchi, K.; Kazuta, Y.; Hirano, K.; Yamada,S.; Matsuda, A.; Shuto, S.
Synthesis of 1-arylpiperazyl-2-phenylcyclopropanes designed as antidopaminergic agents: Cyclopropane-based conformationally restricted analogs of haloperidol.
Bioorg. Med. Chem. 2008, 16, 8875-8881. DOI: 10.1016/j.bmc.2008.08.061
4.Yasui, H.; Ogura, A. Asanuma, T.; Matsuda, A.; Kashiwakura, I.; Kuwabara, M.; Inanami, O.
Inhibition of HIF-1α by the anticancer drug TAS106 enhances X-ray-induced apoptosis in vitro and in vivo.
Br. J. Cancer 2008, 99, 1442-1452. DOI: 10.1038/sj.bjc.6604720
6.Yoshida, K.; Yamaguchi, K.; Sone, T.; Unno, Y.; Asai, A.; Yokosawa, H.; Matsuda, A.; Arisawa, M.; Shuto, S.
Synthesis of 2,3- and 3,4-methanoamino acid equivalents with stereochemical diversity and their conversion into the tripeptide proteasome inhibitor belactosin A and its highly potent cis-cyclopropane stereoisomer.
Org. Lett. 2008, 10, 3571-3574. DOI: 10.1021/ol8013304
7.Sakaguchi, N.; Kudoh, T.; Tsuzuki, T.; Murayama, T.; Sakurai, T.; Matsuda, A.; Arisawa, M.; Shuto, S.
Synthesis of 5´´-branched derivatives of cyclic ADP-carbocyclic-ribose, a potent Ca2+-mobilizing agent: The first antagonists modified at the N1-ribose moiety.
Bioorg. Med. Chem. Lett. 2008, 18, 3814-3818. DOI: 10.1016/j.bmcl.2008.04.083
8.Kudoh, T.; Weber, K.; Guse, A. H.; Potter, B. V. L.; Hashii, M.; Higashida, H.; Arisawa, M.; Matsuda, A.; Shuto, S.
Design and aynthesis of 4´´,6´´-unsaturated cyclic ADP-carbocyclic ribose as a Ca2+-mobilizing agent.
Tetrahedron Lett. 2008, 49, 3976-3979. DOI: 10.1016/j.tetlet.2008.04.100
11.Wang, Y.; Liu, X.; Matsuda, A.; Plunkett, W.
Repair of 2´-C-cyano-2´-deoxy1-β-D-arabino-pentofuranosylcytosine-induced DNA single-strand breaks by transcription-coupled nucleotide excision repair.
Cancer Res. 2008, 68, 3881-3889. DOI: 10.1158/0008-5472.CAN-07-6885
13.Matsugami, A.; Ohmiya, T.; Inada, M.; Inoue, N.; Minakawa, N.; Matsuda, A.; Katahara, M.
Unexpected A form formation of 4´-thioDNA in solution, as revealedby NMR, and the implication on the machanism of nuclease-resistance.
Nucleic Acids Res. 2008, 36, 1805-1812. DOI: 10.1093/nar/gkn011
15.Liu, X.; Matsuda, A.; Plunkett, W.
ATR and DNA-PK cooperate in G2 checkpoint activation by the DNA strand-breaking nucleoside analogue, CNDAC.
Mol. Cancer Ther. 2008, 7, 133-142. DOI: 10.1158/1535-7163.MCT-07-0416
19.周東 智、市川 聡、阿部 洋、松田 彰
ピラノースの配座制御に基づく立体選択的グリコシル化反応.
有機合成化学協会誌, 2008, 66, 50-59.
20.松田 彰
核酸化学から創薬へ (創薬最前線).
MEDCHEM NEWS, 2008, 18 (1), 2-6.
21.村中 一大、市川 聡、松田 彰
Structure-Based Drug Designによる分子シャペロンHsp90阻害剤の創製研究
MEDCHEM NEWS 2008, 18 (3), 52-58.
22.Matsuda, A.
1-(3-C-Ethynyl-β-D-ribo-pentofuranosyl)cytosine (ECyd).
Modified Nucleosides: in Biochemistry, Biotechnology and Medicine, Ed. By P. Herdewijn, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, pp483-495.
All Rights Reserved Laboratory of Medicinal Chemistry